UA92736C2 - Похідні 1н-імідазолу як модулятори рецепторів канабіноїдів св2 - Google Patents

Похідні 1н-імідазолу як модулятори рецепторів канабіноїдів св2

Info

Publication number
UA92736C2
UA92736C2 UAA200710205A UAA200710205A UA92736C2 UA 92736 C2 UA92736 C2 UA 92736C2 UA A200710205 A UAA200710205 A UA A200710205A UA A200710205 A UAA200710205 A UA A200710205A UA 92736 C2 UA92736 C2 UA 92736C2
Authority
UA
Ukraine
Prior art keywords
imidazole derivatives
cannabinoid
receptor modulators
cbreceptors
compounds
Prior art date
Application number
UAA200710205A
Other languages
English (en)
Russian (ru)
Inventor
Йозефус Х.М. Ланге
Герман Г. Стьойвенберг
Флит Бернард Ж. ван
Original Assignee
Сольве Фармасьютикалз Б.В.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Сольве Фармасьютикалз Б.В. filed Critical Сольве Фармасьютикалз Б.В.
Publication of UA92736C2 publication Critical patent/UA92736C2/uk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Винахід стосується групи похідних 1Н-імідазолу як модуляторів рецепторів канабіноїдів СВ, способів одержання цих сполук, проміжних сполук, придатних для синтезу зазначених похідних імідазолу, способів одержання цих проміжних сполук, фармацевтичних композицій, що містять одне або кілька зазначених похідних 1Н-імідазолу як діючі речовини, а також застосування цих фармацевтичних композицій для лікування розладів, пов'язаних з рецепторами канабіноїдів СВ.Сполуки мають загальну формулу (І), (I)де R-Rмають значення, наведені в описі.
UAA200710205A 2005-02-16 2006-02-16 Похідні 1н-імідазолу як модулятори рецепторів канабіноїдів св2 UA92736C2 (uk)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP05101171 2005-02-16

Publications (1)

Publication Number Publication Date
UA92736C2 true UA92736C2 (uk) 2010-12-10

Family

ID=34938748

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200710205A UA92736C2 (uk) 2005-02-16 2006-02-16 Похідні 1н-імідазолу як модулятори рецепторів канабіноїдів св2

Country Status (5)

Country Link
KR (1) KR20070107130A (uk)
CN (1) CN101107233A (uk)
AR (1) AR052666A1 (uk)
TW (1) TW200640876A (uk)
UA (1) UA92736C2 (uk)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3312170A4 (en) * 2015-06-22 2018-12-12 Sumitomo Dainippon Pharma Co., Ltd. 1,4-di-substituted imidazole derivative
WO2016208592A1 (ja) * 2015-06-22 2016-12-29 大日本住友製薬株式会社 二環性複素環アミド誘導体
CN107663159A (zh) * 2016-07-29 2018-02-06 上海迪诺医药科技有限公司 多环化合物、其药物组合物及应用

Also Published As

Publication number Publication date
AR052666A1 (es) 2007-03-28
KR20070107130A (ko) 2007-11-06
TW200640876A (en) 2006-12-01
CN101107233A (zh) 2008-01-16

Similar Documents

Publication Publication Date Title
NO20074710L (no) 1H-Imidazolderivater som cannabinoid-CB2-receptormodulatorer
WO2009010871A3 (en) Pyrazole derivatives as antagonists of adenosine a3 receptor
BRPI0507005A (pt) compostos, composições farmacêuticas, uso de um composto, e, método de preparo de uma composição farmacêutica
IL176546A0 (en) Imidazoline derivatives having cb1-antagonistic activity
EA200870079A1 (ru) Замещенные имидазолы и их применение в качестве пестицидов
MX2007002393A (es) Compuestos indolicos sustituidos y su uso como moduladores del receptor de 5-hidroxitriptamina 6 (5-ht6).
MX2008002805A (es) Derivados de carboxamida como antagonistas del receptor muscarinico.
MX2007011847A (es) Derivados de pirimidindiona como antagonistas del receptor de procineticina 2.
TW200714587A (en) Biphenyl compounds useful as muscarinic receptor antagonists
WO2005060959A8 (en) Pyrazole derivatives and use thereof as orexin receptor antagonists
MX2011006132A (es) Imidazol carboxamidas fusionadas como moduladores de trpv3.
WO2009116074A3 (en) Substituted benzimidazoles as cannabinoid modulator
NO20062249L (no) 1H-imidazolderivater som cannabionidreseptor modulatorer
WO2007042544A3 (en) Imidazole derivatives and their use for modulating the gabaa receptor complex
MX2010005704A (es) Derivados de cromano como modulares del trpv3.
MX2009008324A (es) Compuestos 6´-sustituidos que tienen afinidad con el receptor de 5-hidroxitriptamina-6.
WO2010073128A3 (en) Fused imidazole derivatives as trpv3 antagonist
EA200870606A1 (ru) Серосодержащие производные пиразола в качестве избирательных антагонистов рецептора каннабиноидов св
UA100862C2 (uk) Шестичленні ароматичні сполуки, їх одержання та застосування (варіанти)
UA92736C2 (uk) Похідні 1н-імідазолу як модулятори рецепторів канабіноїдів св2
UA104861C2 (uk) Похідні хроману як модулятори trpv3
WO2009034432A8 (en) Novel compounds active as muscarinic receptor antagonists
EA201190003A1 (ru) Производные хроменона в качестве trpv3 антагонистов
EA201071227A1 (ru) (5r)-1,5-диарил-4,5-дигидро-1h-пиразол-3-карбоксамидиновые производные, обладающие св1-антагонистической активностью
TW200730500A (en) 4, 5-dihydro-(1H)-pyrazole derivatives as cannabinoid CB1 receptor modulators